This is a 12-month, 3-arm randomized controlled trial of 315 Childhood Cancer Survivor Study
(CCSS) survivors using a text message intervention with data collected at baseline and 12
months through patient and provider surveys and interviews and a medical record review.
Participants will be randomly assigned to one of three groups: control, patient activation
(PA) using a text message/video intervention, or patient activation + primary care provider
activation (PA + PCP) which will include providing primary care providers with resources
about colorectal cancer risk in this population. All participants will receive electronic
resources about their previous cancer treatment and colorectal cancer screening
recommendations.
The primary outcome is the proportion of patients who complete the colonoscopy or Cologuard
test (Cologuard test plus colonoscopy if the Cologuard is positive) within 12 months of
enrolling on the study, as measured via self-report questions in the end of study
questionnaire. The study will test the hypothesis that, compared to controls, survivors
randomized to the PA and PA + PCP activation groups will have significantly higher rates of
completion of colorectal cancer screening.
